TY - CHAP
T1 - Vitamin D
T2 - Cardiovascular effects and vascular calcification
AU - Towler, Dwight A.
N1 - Funding Information:
D.A.T. is supported by NIH grants HL69229, HL81138, HL88651, and the Barnes-Jewish Hospital Foundation.
PY - 2011
Y1 - 2011
N2 - The role of vitamin D in skeletal physiology and calcium/phosphate homeostasis is well recognized. This chapter provides an overview of vitamin D in cardiovascular physiology and toxicology. Vitamin D plays a biphasic role in human health, with both insufficiency and intoxication compromising cardiovascular physiology. Vitamin D agonists (VDRAs) are vasculotropic hormones, and vitamin D insufficiency is associated with significant, undesirable changes in cardiovascular physiology and structure. In end-stage renal disease, benefits of pharmacological enhancement of vitamin D receptor (VDR) tone with VDRAs have emerged, likely via improvements in endothelial function and reductions in myocardial hypertrophic responses. Vitamin D intoxication also exerts significant undesirable actions on the cardiovascular system via elevations in serum phosphate and serum calcium/calciproteins, impairment of VSMC elastin biology, and inhibition of protective vascular PTH/PTHrP receptor signaling. Histoanatomic, molecular, and ethnic heterogeneities are emerging in the pathobiology of arteriosclerotic disease; these heterogeneities confound straightforward extrapolation of the downsides of insufficiency to benefits with repletion or supplementation. Dynamic interactions between the parathyroids, kidneys, and bone determine the toxicity threshold for vitamin D and calcium-i.e. whether hypervitaminosis D or excessive calcium intake is also associated with toxicity. The relationships between the VDR, its non-nuclear role in mitochondrial function and cardiovascular oxidative stress signaling have yet to be detailed.
AB - The role of vitamin D in skeletal physiology and calcium/phosphate homeostasis is well recognized. This chapter provides an overview of vitamin D in cardiovascular physiology and toxicology. Vitamin D plays a biphasic role in human health, with both insufficiency and intoxication compromising cardiovascular physiology. Vitamin D agonists (VDRAs) are vasculotropic hormones, and vitamin D insufficiency is associated with significant, undesirable changes in cardiovascular physiology and structure. In end-stage renal disease, benefits of pharmacological enhancement of vitamin D receptor (VDR) tone with VDRAs have emerged, likely via improvements in endothelial function and reductions in myocardial hypertrophic responses. Vitamin D intoxication also exerts significant undesirable actions on the cardiovascular system via elevations in serum phosphate and serum calcium/calciproteins, impairment of VSMC elastin biology, and inhibition of protective vascular PTH/PTHrP receptor signaling. Histoanatomic, molecular, and ethnic heterogeneities are emerging in the pathobiology of arteriosclerotic disease; these heterogeneities confound straightforward extrapolation of the downsides of insufficiency to benefits with repletion or supplementation. Dynamic interactions between the parathyroids, kidneys, and bone determine the toxicity threshold for vitamin D and calcium-i.e. whether hypervitaminosis D or excessive calcium intake is also associated with toxicity. The relationships between the VDR, its non-nuclear role in mitochondrial function and cardiovascular oxidative stress signaling have yet to be detailed.
UR - http://www.scopus.com/inward/record.url?scp=84884778187&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884778187&partnerID=8YFLogxK
U2 - 10.1016/B978-0-12-381978-9.10073-3
DO - 10.1016/B978-0-12-381978-9.10073-3
M3 - Chapter
AN - SCOPUS:84884778187
SN - 9780123819789
SP - 1403
EP - 1426
BT - Vitamin D
PB - Elsevier Inc.
ER -